Current Drug Targets - Inflammation & Allergy
Discontinued in 2005. Continued by Inflammation & Allergy-Drug Targets (1871-5281). Current Drug Targets - Inflammation & Allergy aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in inflammation and allergy e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will contain a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in inflammation and allergy. As the discovery, identification, characterization and validation of novel human drug targets for anti-inflammation and allergy drug discovery continues to grow, this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.
- Further information
- Category Links